Zobrazeno 1 - 10
of 31
pro vyhledávání: '"Chrissy Giles"'
Publikováno v:
Haematologica, Vol 96, Iss 4 (2011)
Externí odkaz:
https://doaj.org/article/eb0a6596af6b4f00b8e565062ed3bff1
Autor:
Donald Macdonald, Kikkeri N. Naresh, Alejandro Contento, Jane F. Apperley, Holger W. Auner, Sarah Ellis, Edward Kanfer, Amin Rahemtulla, Richard Szydlo, Chrissy Giles, Jiří Pavlů
Publikováno v:
Hematological Oncology. 29:75-80
High-dose chemotherapy followed by autologous stem cell transplantation (ASCT) is a recognized treatment option for patients with relapsed diffuse large B-cell lymphoma. We have analysed 51 patients who underwent ASCT after LACE (lomustine (CCNU), cy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2a79b40476497bbc9883c305fae7e5c6
https://doi.org/10.1002/hon.956
https://doi.org/10.1002/hon.956
Autor:
Eduardo Olavarria, Evangelos Terpos, J. F. Apperley, Chrissy Giles, Diana Samson, Charles Crawley, Amin Rahemtulla, Edward Kanfer, J. M. Goldman
Publikováno v:
Bone Marrow Transplantation. 31:163-170
High-dose therapy with autologous stem cell transplantation (ASCT) has become the treatment of choice for symptomatic eligible patients with multiple myeloma (MM). We report our centre experience and analyse retrospectively the prognostic influence o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::afe59af086b41ff079c6d91f351d146c
https://doi.org/10.1038/sj.bmt.1703818
https://doi.org/10.1038/sj.bmt.1703818
Publikováno v:
British Journal of Haematology. 155:509-511
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cca26c83b28fe35ef8b5198260c9da35
https://doi.org/10.1111/j.1365-2141.2011.08700.x
https://doi.org/10.1111/j.1365-2141.2011.08700.x
Autor:
M. Boots, R. Parameswaran, T. J. Littlewood, Stephen M. Kelsey, Diana Samson, M. J. Mills, Chrissy Giles
Publikováno v:
British Journal of Haematology. 109:571-575
We report the results of a non-randomized pilot study of an oral regimen comprising CCNU (lomustine; 25 or 50 mg/m2 on day 1), idarubicin (4-demethoxydaunorubicin) (10 mg/m2 on days 1-3) and dexamethasone (10 mg b.d. on days 1-4) in patients with rel
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ea8b6606ad75e77542a4b343f0636842
https://doi.org/10.1046/j.1365-2141.2000.02082.x
https://doi.org/10.1046/j.1365-2141.2000.02082.x
Autor:
Craig M. McDonald, S Armitage, D. Gupta, A. Bybee, Diana Samson, Edward Kanfer, Chrissy Giles, D. Mcguigan, J. F. Apperley, F. Cooke, M. P. A. Lyttelton, J. G. Davis
Publikováno v:
British Journal of Haematology. 104:166-177
Thirty-six patients with multiple myeloma (23 PR1, nine PR2, four stable disease) were entered into a pilot study evaluating the use of CD34+-selected peripheral blood progenitor cell transplantation (PBPCT) following high-dose melphalan alone or hig
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ef7a140601277ba340a4a26cefca6bb2
https://doi.org/10.1046/j.1365-2141.1999.01133.x
https://doi.org/10.1046/j.1365-2141.1999.01133.x
Autor:
Edward Kanfer, D. Samson, G. J. S. Rustin, M. P. A. Lyttelton, Chrissy Giles, E. S. Newlands, Mark Bower, S.M. O'Reilly, A. Guimaraes
Publikováno v:
British Journal of Cancer
Thirty-one consecutive patients with relapsed or refractory GCT received an HDT schedule including carboplatin, the dose of which was adjusted to measured glomerular filtration rate. There was one HDT-associated death (3%), due to acute renal failure
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4a64b0f12a92fa539f00d38230a37e3b
http://europepmc.org/articles/PMC2150058
http://europepmc.org/articles/PMC2150058
Autor:
Donald Macdonald, Richard Szydlo, Jiri Pavlu, Aristeidis Chaidos, David Marin, Chrissy Giles, Holger W. Auner, Ed Kanfer, Amin Rahemtulla, Dragana Milojkovic, Alero Rone, Jane F. Apperley
Publikováno v:
Leukemialymphoma. 54(10)
Progression or relapse occurs in the vast majority of patients with multiple myeloma (MM) who undergo up-front autologous hematopoietic cell transplantation (AHCT1), which remains a cornerstone of treatment in the era of novel agents. Limited data ar
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::aa5bf0885d0841336360e4e112cc1d49
https://pubmed.ncbi.nlm.nih.gov/23488606
https://pubmed.ncbi.nlm.nih.gov/23488606
Autor:
David Marin, Richard Szydlo, Jiri Pavlu, Katayoun Rezvani, Holger W. Auner, John M. Goldman, Chrissy Giles, Jane F. Apperley, Ola Landgren, Ed Kanfer, Amin Rahemtulla, Dragana Milojkovic, Donald Macdonald
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f7d53b853c57e9d2f484fe3d4c880b55
https://europepmc.org/articles/PMC6896783/
https://europepmc.org/articles/PMC6896783/
Autor:
G. F. Lucas, Chrissy Giles, Katy Rezvani, Kate Cwynarski, J. M. Goldman, Christopher Pocock, J. F. Apperley, George S. Vassiliou
Publikováno v:
British Journal of Haematology. 113:483-485
A case of immune neutropenia following unrelated stem cell transplantation for chronic myeloid leukaemia is described. The neutropenia developed following herpes zoster viral infection and was associated with antibodies to the human neutrophil antige
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::28dccb7352806970f9ac0bed05df01a9
https://doi.org/10.1046/j.1365-2141.2001.02779.x
https://doi.org/10.1046/j.1365-2141.2001.02779.x